European Parliament - EU Strategy on COVID-19 vaccines must guarantee safety and accessibility for all
22 June 2020 |Parliament's Committee responsible for public health debated how to support efforts to develop and manufacture COVID-19 vaccines, together with Commissioner Kyriakides.
-
Commission proposes a temporary derogation from clinical trials involving GMOs
-
The Vaccine Alliance by four EU member states complementary to EU Strategy
-
Communication on the “risk of a second wave” issued by Commission on 15 July
Read more at the link below.